Because bone marrow transplantation has emerged as a major treatment option for RDEB we sought to determine whether hematopoietic stem cells (HSC) were permissive to COL7A1 targeting and gene upregulation. This evidence concerns the gene COL7A1 and recessive dystrophic epidermolysis bullosa.